Definição de um modelo de análise de sucesso das empresas baseado em índices contábeis e na análise multivariada

The objective of this paper is to relate the set of financial ratios that are directly related to the success of public traded companies using a methodological approach and the method of multivariate principal component analysis. This study consists in the use of profitability ratios, debt and liquidity, to define the relationship between financial ratios with the best public traded companies listed in the magazine Exame Melhores e Maiores of 2013. Multivariate analysis was used to reduce the dimensionality of multivariate data, making linear combinations of the original variables (financial ratios) and express the data in principal components that result in new variables that contains much of the original data. As a result, we got the optimal number of five principal components, and both represent 95.6% of the original data. Among of all financial ratios, we can highlight the direct relationship between profitability ratios for the first principal component, and the direct relationship between the liquidity ratios, both inversely related with non-capital participation rates and degree indebtedness to the second principal component

Administration of beta(2)-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles

Purpose: the objective of the present investigation was to determine implantation and pregnancy rates in patients undergoing ICSI and treated with beta(2)-adrenergic agonists, considering the uterine-relaxing action of these agents.Methods: A total of 225 women undergoing ICSI at the Center for Human Reproduction, Sinha Junqueira Maternity Foundation, entered the study. Patient participation in each group was random, by drawing lots, using a randomization table previously elaborated for the study (2:2:1). The group I (90 women) received 10 mg of terbutaline daily for 15 days starting on the day of oocyte retrieval; group II (90 women) received 20 mg of ritodrine daily during the same period of time as group I; group III (45 patients) received no treatment and was used as control. The evaluation was interrupted in 3 patients of group I and in 30 patients of group II because of a high incidence of side effects.Results: Pregnancy, implantation, and miscarriage rates were not significantly different (p>0.05) between the three groups: 29.88%, 13.25%, and 26.9% for group I; 33.33%, 17.5%, and 10.0% for group II; 28.88%, 15.07%, and 15.38% for group III, respectively.Conclusions: the results of this study do not support the routine use of beta(2)-adrenergic agonists during the peri-implantation period in assisted reproductive technology cycles.